Alternatives to SpliceBio

SpliceBio is a Biotechnology tool: biotechnology company developing next-generation gene therapies using a proprietary protein splicing platform. Here are the 60 closest alternatives, compared on pricing, features and what real users say.

SpliceBio profile Open source alternatives (3)More Biotechnology alternatives

The 20 closest Biotechnology companies to SpliceBio

Website
Spark Therapeutics58
BiotechnologyPhiladelphia, United States$82.8M
A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
Website
Moderna77
BiotechnologyCambridge, United States$4.5B
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Website
Epicrispr Biotechnologies62
BiotechnologySouth San Francisco, United States$90.0M
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Website
Pixelgen Technologies62
BiotechnologyStockholm, Sweden$43.5M
A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Website
Infinimmune60
BiotechnologyAlameda, United States$75.0M
Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Website
Quartzy60
BiotechnologyHayward, USA$40.0M
A vertically-integrated procurement platform for the life sciences industry.
Website
Network Bio60
BiotechnologyPalo Alto, United States$100.0M
Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.
Website
LifeMine Therapeutics Inc.60
BiotechnologyWatertown, United States$543.0M
Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
Website
Freenome59
BiotechnologySouth San Francisco, USA$570.0M
Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
Website
Mironid59
BiotechnologyGlasgow, United Kingdom$46.0M
Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Website
KaliVir Immunotherapeutics, Inc.57
BiotechnologyPittsburgh, United States$14.0M
Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
Website
Adaptyv Biosystems57
BiotechnologyLausanne, Switzerland$40.0M
Automated wet lab for AI-driven protein design, enabling rapid synthesis, expression, and testing of thousands of protein designs.
Website
Arc Institute56
BiotechnologyPalo Alto, United States$650.0M
A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.
Website
Verve Therapeutics56
BiotechnologyCambridge, USA$300.0M
Developing gene editing therapies to lower cholesterol.
EA
Earendil Labs56
BiotechnologyBeijing, China$787.0M
Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.
Website
Latus Bio54
BiotechnologyBoston, USA$151.0M
Engineering scalable gene therapies for broader patient populations.
Website
Transcripta Bio54
BiotechnologyPalo Alto, United States$24.0M
AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.
Website KH
Khartis Therapeutics, Inc.53
BiotechnologySan Diego, United States$50.0M
Developing oral small molecule medicines for immunological and chronic diseases.
Website
Ray Therapeutics53
BiotechnologyBerkeley, USA$243.0M
Pioneering vision restoration therapies for severe retinal degenerations.
Website
Waypoint Bio53
BiotechnologyNew York, USA$20.0M
AI-native biotech company designing next-generation CAR T therapies for solid tumors.

Company	Sector	HQ	Funding	Score	Website
Spark TherapeuticsA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.	Biotechnology	Philadelphia, United States	$82.8M	58	Website
ModernaModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.	Biotechnology	Cambridge, United States	$4.5B	77	Website
Epicrispr BiotechnologiesEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).	Biotechnology	South San Francisco, United States	$90.0M	62	Website
Pixelgen TechnologiesA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.	Biotechnology	Stockholm, Sweden	$43.5M	62	Website
InfinimmuneDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.	Biotechnology	Alameda, United States	$75.0M	60	Website
QuartzyA vertically-integrated procurement platform for the life sciences industry.	Biotechnology	Hayward, USA	$40.0M	60	Website
Network BioLeveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.	Biotechnology	Palo Alto, United States	$100.0M	60	Website
LifeMine Therapeutics Inc.Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.	Biotechnology	Watertown, United States	$543.0M	60	Website
FreenomeFreenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.	Biotechnology	South San Francisco, USA	$570.0M	59	Website
MironidBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).	Biotechnology	Glasgow, United Kingdom	$46.0M	59	Website
KaliVir Immunotherapeutics, Inc.Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.	Biotechnology	Pittsburgh, United States	$14.0M	57	Website
Adaptyv BiosystemsAutomated wet lab for AI-driven protein design, enabling rapid synthesis, expression, and testing of thousands of protein designs.	Biotechnology	Lausanne, Switzerland	$40.0M	57	Website
Arc InstituteA nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.	Biotechnology	Palo Alto, United States	$650.0M	56	Website
Verve TherapeuticsDeveloping gene editing therapies to lower cholesterol.	Biotechnology	Cambridge, USA	$300.0M	56	Website
EAEarendil LabsEarendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.	Biotechnology	Beijing, China	$787.0M	56
Latus BioEngineering scalable gene therapies for broader patient populations.	Biotechnology	Boston, USA	$151.0M	54	Website
Transcripta BioAI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.	Biotechnology	Palo Alto, United States	$24.0M	54	Website
KHKhartis Therapeutics, Inc.Developing oral small molecule medicines for immunological and chronic diseases.	Biotechnology	San Diego, United States	$50.0M	53	Website
Ray TherapeuticsPioneering vision restoration therapies for severe retinal degenerations.	Biotechnology	Berkeley, USA	$243.0M	53	Website
Waypoint BioAI-native biotech company designing next-generation CAR T therapies for solid tumors.	Biotechnology	New York, USA	$20.0M	53	Website

Showing the 20 closest matches. See the rest on the SpliceBio profile.